Although the numbers were far below what I was expecting, I felt a lot better reading the commentary in the report. There are still numerous revenue streams that are likely to experience continued growth. I'm especially interested in how the South African trial goes. If that is successful and can be rolled out in other schools that has huge leverage potential.
Disappointed with the numbers, but long term I'm still confident in substantial EPS growth
Ann: App 4E / Full Year Statutory Accounts, page-5
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add KME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $27.00M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 45.5¢ | 44.0¢ | $12.94K | 28.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13805 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 2770 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| KME (ASX) Chart |
